Serial MRI Scans During Radiation Therapy

This is a phase 1 study to determine the feasibility and utility of using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy (standard of care cancer treatment) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma. The research study procedures include three MRI scans (one before, one during, and one after standard of care cancer radiation therapy) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma. The research stu

Trial Details

NCT ID
NCT04188535
Phase
NA
Sponsor
Dana-Farber Cancer Institute
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • MRI IMAGING
Locations (sample)
  • Boston, Massachusetts, United States|42.35843,-71.05977
  • Boston, Massachusetts, United States|42.35843,-71.05977

Key Eligibility Criteria

  • Participants must have a confirmed malignancy requiring radiation therapy.
  • Age: 18 years or older except where otherwise specified in subprotocol.
  • ECOG performance status ≤2 (Karnofsky ≥60%)
  • Ability to understand and the willingness to sign a written informed consent document.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →